About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Washington | 675 Studies

Clinical Trials Prostate CancerWashington

Prostate Cancer Clinical Trials in Washington

Find 675 clinical trials for prostate cancer near Washington. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Washington

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 301-320 of 675 trials

CompletedAnalyses of Human Samples Collected in Clinical TrialsCancer patients in clinical trials donate various human samples (e.g., serum, plasma, blood, urine, feces, bile, saliva) for research purposes.NCT00339664·Washington D.C., District of Columbia and 16 others TerminatedA Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate CancerThe purpose of this study is to assess the safety, efficacy, tolerability, and toxicity of docetaxel alone, in combination with BMS-986218, or in combination with nivolumab plus…NCT05169684·Tucson, Arizona and 30 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedObservational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate CancerObservational study in the routine clinical practice setting to evaluate the short and long term safety profile of Radium-223 in metastatic castration resistant prostate cancer…NCT02141438·Anchorage, Alaska and 67 others

CompletedA Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With EnzalutamideThe objective of this study was to evaluate the incidence of seizures and monitor the safety of enzalutamide treatment in participants with metastatic castration-resistant…NCT01977651·Anchorage, Alaska and 75 others

Active not recruitingpTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate CancerThis trial will evaluate the use of one versus two DNA vaccines, delivered concurrently with PD-1 blockade using pembrolizumab followed by treatment with pembrolizumab alone, and…NCT04090528·St Louis, Missouri and 1 other

CompletedChemotherapy After Prostatectomy (CAP) For High Risk Prostate CarcinomaVA Cooperative Study #553 is designed to prospectively evaluate the efficacy of early adjuvant chemotherapy using docetaxel and prednisone added to the standard of care for…NCT00132301·Birmingham, Alabama and 33 others

CompletedRadiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical ProstatectomyRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Androgens can stimulate the growth of prostate cancer cells.NCT00002874·Birmingham, Alabama and 239 others

RecruitingStudy of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)This is a phase 3, randomized, open-label study of opevesostat compared to alternative abiraterone acetate or enzalutamide in participants with metastatic castration-resistant…NCT06136624·Orange, California and 287 others

CompletedEMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate CancerThe primary objective of the trial is to evaluate the clinical anti-tumor activity of EMD 525797 administered as 1-hour intravenous infusion every 3 weeks in terms of progression…NCT01360840·Pleasant Hill, California and 70 others

RecruitingImpact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceThe impact of fluciclovine (18F) PET on the management of participants with prostate cancer following negative or equivocal PSMA PET Imaging at the time of biochemical recurrenceNCT07569926·San Diego, California and 5 others

CompletedMaximal Suppression of the Androgen Axis in Clinically Localized Prostate CancerProstate cancer (CaP) is the most commonly diagnosed cancer among males in the U.S. and the second leading cause of cancer-related mortality.NCT00298155·Seattle, Washington and 1 other

Active not recruitingAn Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLASThe purpose of this study is to determine if apalutamide plus gonadotropin releasing hormone (GnRH) agonist in participants with high-risk, localized or locally advanced prostate…NCT02531516·Homewood, Alabama and 262 others

Recruiting64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)The aim of this study is to determine the safety and efficacy of 67Cu-SAR-bisPSMA in participants with PSMA-expressing metastatic castrate resistant prostate cancer.NCT04868604·Stanford, California and 6 others

CompletedUse of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate CancerThe main purpose of this study to define the good and/or bad effects of the combination of enzalutamide and CC-115 in patients with castration-resistant prostate cancer.NCT02833883·San Francisco, California and 4 others

Active not recruitingStudy of Oral MRT-2359 in Selected Cancer PatientsThis Phase 1/2, open-label, multicenter study is conducted in patients with previously treated selected solid tumors, including non-small cell lung cancer (NSCLC), small cell lung…NCT05546268·Scottsdale, Arizona and 16 others

CompletedDose Escalation and Efficacy Trial of GVAX® Prostate Cancer VaccineThe purpose of this study is to evaluate clinical and laboratory safety in patients receiving 4 different doses of GVAX® Prostate Cancer Vaccine in order to determine a maximum…NCT00140348·Laguna Woods, California and 11 others

CompletedA Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate CancerThis is a Phase 3 randomized, double blind, placebo controlled study of tasquinimod in asymptomatic to mildly symptomatic patients with metastatic CRPC to confirm the effect of…NCT01234311·Tucson, Arizona and 203 others

Active not recruitingProstate Cancer Prospective CohortThe overall purpose of this research is to determine if certain genes increase the chance of developing prostate cancer and once diagnosed increase the chance of the prostate…NCT00937586·St Louis, Missouri

TerminatedPhenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With DocetaxelThis phase II trial studies how well giving phenelzine sulfate together with docetaxel works in treating patients with prostate cancer that is growing, spreading, or getting worse…NCT01253642·Portland, Oregon and 2 others

RecruitingCARE Tool Study Aim 3This study is a multi-site randomized trial to study the implementation of the CARE Tool and evaluate the CARE Tool.NCT07296887·Alton, Illinois and 2 others

PreviousPage 16 of 34Next

Other Conditions in Washington

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma